Suggestions
Daniel Winkler
Founder of atEM, Enabling structure based drug design
Daniel Winkler is a visionary entrepreneur passionate about leveraging cryo-electron microscopy (cryo-EM) to provide pharmaceutical companies with a deeper insight into their drug targets for enhanced rational drug design. He is the founder of atEM.bio, a company dedicated to supporting organizations in processing their cryo-EM data to achieve optimal 3D atomic models of hard drug targets. With a Master's degree in Business, Management, Marketing, and related support services from WHU – Otto Beisheim School of Management, Daniel combines technical expertise with a profound understanding of biochemistry to drive innovation in structural biology. Previously, he held key roles as the Head Of Business Development at Digital Project 1 and as the Chief Sales Officer at viacash, viafintech solutions.
